Neuropilin-1 (NRP1) is a co-receptor for multiple extracellular ligands. NRP1 is widely expressed in cancer cells and in advanced human tumors; however, its functional relevance and signaling mechanisms are unclear. Here we show that NRP1 expression controls viability and proliferation of different cancer cells, independent of its short intracellular tail. We found that the extracellular domain of NRP1 interacts with the Epidermal Growth Factor Receptor (EGFR) and promotes its signaling cascade elicited upon EGF or TGF alpha stimulation. Upon NRP1 silencing, the ability of ligand-bound EGFR to cluster on the cell surface, internalize and activate the downstream AKT pathway is severely impaired. EGFR is frequently activated in human tumors due to overexpression, mutation, or sustained autocrine/paracrine stimulation. Here we show that NRP1-blocking antibodies and NRP1 silencing can counteract ligand-induced EGFR activation in cancer cells. Thus our findings unveil a novel molecular mechanism by which NRP1 can control EGFR signaling and tumor growth.

Neuropilin-1 dependent regulation of EGF-Receptor signaling

RIZZOLIO, Sabrina;LANZETTI, Letizia;SERINI, Guido;TAMAGNONE, Luca
2012-01-01

Abstract

Neuropilin-1 (NRP1) is a co-receptor for multiple extracellular ligands. NRP1 is widely expressed in cancer cells and in advanced human tumors; however, its functional relevance and signaling mechanisms are unclear. Here we show that NRP1 expression controls viability and proliferation of different cancer cells, independent of its short intracellular tail. We found that the extracellular domain of NRP1 interacts with the Epidermal Growth Factor Receptor (EGFR) and promotes its signaling cascade elicited upon EGF or TGF alpha stimulation. Upon NRP1 silencing, the ability of ligand-bound EGFR to cluster on the cell surface, internalize and activate the downstream AKT pathway is severely impaired. EGFR is frequently activated in human tumors due to overexpression, mutation, or sustained autocrine/paracrine stimulation. Here we show that NRP1-blocking antibodies and NRP1 silencing can counteract ligand-induced EGFR activation in cancer cells. Thus our findings unveil a novel molecular mechanism by which NRP1 can control EGFR signaling and tumor growth.
2012
72
22
5801
5811
http://cancerres.aacrjournals.org/content/72/22/5801.long
EGF; Neuropilin; Receptors; signaling; TGF-alpha; Tumor
Rizzolio S; Rabinowicz N; Rainero E; Lanzetti L; Serini G; Norman JC; Neufeld G; Tamagnone L.
File in questo prodotto:
File Dimensione Formato  
2012_Neuropilin-1 dependent regulation of EGF-Receptor signaling.pdf

Accesso aperto

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 442.7 kB
Formato Adobe PDF
442.7 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/122273
Citazioni
  • ???jsp.display-item.citation.pmc??? 50
  • Scopus 85
  • ???jsp.display-item.citation.isi??? 77
social impact